RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Understanding Parkinson's Disorders: Classification and Evaluation Methods, Movement Disorders, and Treatment Methods

      한글로보기

      https://www.riss.kr/link?id=A108778317

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Parkinson's disease is a complex neurodegenerative disease characterized by the progressive loss of dopamine-producing neurons in the substantia nigra, resulting in a variety of motor and non-motor symptoms. This study aimed to provide a comprehensive overview of Parkinson's disease, including classification of Parkinson's disease, impairment due to impairment, how disability is assessed, and how it is treated. Major symptoms of Parkinson's disease include tremors, stiffness, bradykinesia, and postural instability, and treatment methods include rehabilitation through drugs, surgical procedures, physical therapy, and occupational therapy. Early diagnosis, individualized treatment interventions, and comprehensive treatment involving a multidisciplinary medical team will be essential to manage Parkinson's disease and improve patients' quality of life. In conclusion, this study will provide comprehensive information on the complex nature of Parkinson's disease and serve as a useful guide for healthcare providers designing treatment plans for Parkinson's patients.
      번역하기

      Parkinson's disease is a complex neurodegenerative disease characterized by the progressive loss of dopamine-producing neurons in the substantia nigra, resulting in a variety of motor and non-motor symptoms. This study aimed to provide a comprehensive...

      Parkinson's disease is a complex neurodegenerative disease characterized by the progressive loss of dopamine-producing neurons in the substantia nigra, resulting in a variety of motor and non-motor symptoms. This study aimed to provide a comprehensive overview of Parkinson's disease, including classification of Parkinson's disease, impairment due to impairment, how disability is assessed, and how it is treated. Major symptoms of Parkinson's disease include tremors, stiffness, bradykinesia, and postural instability, and treatment methods include rehabilitation through drugs, surgical procedures, physical therapy, and occupational therapy. Early diagnosis, individualized treatment interventions, and comprehensive treatment involving a multidisciplinary medical team will be essential to manage Parkinson's disease and improve patients' quality of life. In conclusion, this study will provide comprehensive information on the complex nature of Parkinson's disease and serve as a useful guide for healthcare providers designing treatment plans for Parkinson's patients.

      더보기

      참고문헌 (Reference)

      1 I. Mazzetta, "Wearable Sensors System for an Improved Analysis of Freezing of Gait in Parkinson’s Disease Using Electromyography and Inertial Signals" 19 (19): 948-, 2019

      2 E. Jaakkola, "Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson’s disease" 24 (24): 1341-1347, 2017

      3 N. Ramsay, "Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson’s disease" 76 : 49-53, 2020

      4 S. Kumar, "Tremor and Rigidity in Patients with Parkinson’s Disease : Emphasis on Epidemiology, Pathophysiology and Contributing Factors" 21 (21): 596-609, 2022

      5 S. Sveinbjornsdottir, "The clinical symptoms of Parkinson’s disease" 139 (139): 318-324, 2016

      6 H. Hasan, "Technologies Assessing Limb Bradykinesia in Parkinson’s Disease" 65-77, 2017

      7 H. -Y. Chu, "Synaptic and cellular plasticity in Parkinson’s disease" 41 (41): 447-452, 2020

      8 C. Chattoraj, "Robotic Assistance in Locomotive Health Recovery : A review" 3 (3): 10-19, 2023

      9 J. Zhang, "Revisiting the Medical Management of Parkinson’s Disease:Levodopa versus Dopamine Agonist" 14 (14): 356-363, 2016

      10 G. Abbruzzese, "Rehabilitation for Parkinson’s disease:Current outlook and future challenges" S60-S64, 2016

      1 I. Mazzetta, "Wearable Sensors System for an Improved Analysis of Freezing of Gait in Parkinson’s Disease Using Electromyography and Inertial Signals" 19 (19): 948-, 2019

      2 E. Jaakkola, "Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson’s disease" 24 (24): 1341-1347, 2017

      3 N. Ramsay, "Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson’s disease" 76 : 49-53, 2020

      4 S. Kumar, "Tremor and Rigidity in Patients with Parkinson’s Disease : Emphasis on Epidemiology, Pathophysiology and Contributing Factors" 21 (21): 596-609, 2022

      5 S. Sveinbjornsdottir, "The clinical symptoms of Parkinson’s disease" 139 (139): 318-324, 2016

      6 H. Hasan, "Technologies Assessing Limb Bradykinesia in Parkinson’s Disease" 65-77, 2017

      7 H. -Y. Chu, "Synaptic and cellular plasticity in Parkinson’s disease" 41 (41): 447-452, 2020

      8 C. Chattoraj, "Robotic Assistance in Locomotive Health Recovery : A review" 3 (3): 10-19, 2023

      9 J. Zhang, "Revisiting the Medical Management of Parkinson’s Disease:Levodopa versus Dopamine Agonist" 14 (14): 356-363, 2016

      10 G. Abbruzzese, "Rehabilitation for Parkinson’s disease:Current outlook and future challenges" S60-S64, 2016

      11 A. Vieira de Moraes Filho, "Progressive Resistance Training Improves Bradykinesia, Motor Symptoms and Functional Performance in Patients with Parkinson’s Disease" 15 : 87-95, 2020

      12 Y. J. Zhao, "Progression of Parkinson’s disease as evaluated by Hoehn and Yahr stage transition times" 25 (25): 710-716, 2010

      13 J. J. Crouse, "Postural instability and falls in Parkinson’s disease" 27 (27): 549-555, 2016

      14 A. H. Snijders, "Physiology of freezing of gait" 80 (80): 644-659, 2016

      15 D. L. M. Radder, "Physical therapy and occupational therapy in Parkinson’s disease" 127 (127): 930-943, 2017

      16 D. G. Rutz, "Physical Therapy for Freezing of Gait and Gait Impairments in Parkinson Disease : A Systematic Review" 12 (12): 1140-1156, 2020

      17 M. S. Islam, "Pesticides and Parkinson’s disease: Current and future perspective" 115 : 101966-, 2021

      18 C. Raza, "Parkinson’s disease: Mechanisms, translational models and management strategies" 226 : 77-90,

      19 D. Fredericks, "Parkinson’s disease and Parkinson’s disease psychosis: a perspective on the challenges, treatments, and economic burden" 23 (23): 83-92, 2017

      20 B. R. Bloem, "Parkinson’s disease" 397 (397): 2284-2303, 2021

      21 M. T. Hayes, "Parkinson’s Disease and Parkinsonism" 132 (132): 807-7201, 2019

      22 E. R. Foster, "Occupational Therapy Interventions for Instrumental Activities of Daily Living for Adults with Parkinson’s Disease: A Systematic Review" 75 (75): 7503190030-, 2021

      23 R. F. Pfeiffer, "Non-motor symptoms in Parkinson’s disease" 22 (22): 119-122, 2016

      24 J. Opara, "Motor assessment in Parkinson`s disease" 24 (24): 411-415, 2017

      25 G. Bonassi, "Mirror Visual Feedback to Improve Bradykinesia in Parkinson’s Disease" e8764238-, 2016

      26 M. Guo, "Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease" 143 (143): 1476-1497, 2020

      27 D. A. Bennett, "Metric properties of nurses’ ratings of parkinsonian signs with a modified Unified Parkinson’s Disease Rating Scale" 49 (49): 1580-1587, 1997

      28 M. K. Mak, "Long-term effects of exercise and physical therapy in people with Parkinson disease" 13 (13): 11-, 2017

      29 M. Senek, "Levodopa-entacapone-carbidopa intestinal gel in Parkinson’s disease : A randomized crossover study" 32 (32): 283-286, 2017

      30 S. Y. H. Lee, "Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies" 28 (28): 485-506, 2022

      31 J. Pérez-Pérez, "Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson’s Disease: A Prospective, Cross-Sectional Study in Non-demented Patients" 32 (32): 401-407, 2015

      32 P. -L. Zhang, "Genetics of Parkinson’s disease and related disorders" 55 (55): 73-80, 2018

      33 A. Mirelman, "Gait impairments in Parkinson’s disease" 18 (18): 697-708, 2019

      34 J. Nonnekes, "Freezing of gait: a practical approach to management" 14 (14): 768-778, 2015

      35 E. R. Foster, "Feasibility of a cognitive strategy training intervention for people with Parkinson’s disease" 40 (40): 1127-1134, 2018

      36 N. A. Gouda, "Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update" 10 (10): 371-, 2022

      37 K. Gordt, "Effects of Wearable Sensor-Based Balance and Gait Training on Balance, Gait, and Functional Performance in Healthy and Patient Populations : A Systematic Review and Meta-Analysis of Randomized Controlled Trials" 64 (64): 74-89, 2018

      38 J. Y. Y. Kwok, "Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People with Parkinson Disease: A Randomized Clinical Trial" 76 (76): 755-763, 2019

      39 C. L. H. Chung, "Effectiveness of resistance training on muscle strength and physical function in people with Parkinson’s disease: a systematic review and meta-analysis" 30 (30): 11-23, 2016

      40 M. J. Armstrong, "Diagnosis and Treatment of Parkinson Disease: A Review" 323 (323): 548-560, 2020

      41 A. Tarakad, "Diagnosis and Management of Parkinson’s Disease" 37 (37): 118-126, 2017

      42 N. Malek, "Deep Brain Stimulation in Parkinson’s Disease" 67 (67): 968-978, 2019

      43 P. Alves Da Rocha, "Complementary physical therapies for movement disorders in Parkinson’s disease: a systematic review" 51 (51): 693-704, 2015

      44 S. Y. Kang, "Characteristics of the sequence effect in Parkinson’s disease" 25 (25): 2148-2155, 2010

      45 Hiroshi Kataoka ; Yohei Okada ; Takao Kiriyama ; Yorihiro Kita ; Junji Nakamura ; Shu Morioka ; Koji Shomoto ; Satoshi Ueno, "Can Postural Instability Respond to Galvanic Vestibular Stimulation in Patients with Parkinson’s Disease?" 대한파킨슨병및이상운동질환학회 9 (9): 40-43, 2016

      46 S. Rinalduzzi, "Balance Dysfunction in Parkinson’s Disease" 2015 : e434683-, 2015

      47 R. Cano-de-la-Cuerda, "Axial rigidity and quality of life in patients with Parkinson’s disease : a preliminary study" 20 (20): 817-823, 2011

      48 A. Mirelman, "Arm swing as a potential new prodromal marker of Parkinson’s disease" 31 (31): 1527-1534, 2016

      49 J. F. Baizabal-Carvallo, "Anti-Gravity Treadmill Training for Freezing of Gait in Parkinson’s Disease" 10 (10): 2020

      50 J. G. V. Habets, "An update on adaptive deep brain stimulation in Parkinson’s disease" 33 (33): 1834-1843, 2018

      51 A. Atik, "Alpha-Synuclein as a Biomarker for Parkinson’s Disease" 26 (26): 410-418, 2016

      52 P. A. Kempster, "A new look at James Parkinson’s Essay on the Shaking Palsy" 69 (69): 482-485, 2007

      53 P. Zham, "A Kinematic Study of Progressive Micrographia in Parkinson’s Disease" 10 : 403-, 2019

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼